Jianda Yuan

26.8k citations

96 papers · 5.3k indexed · 4 hit papers · h-index 36

Impact in

Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 64
- Immunotherapy and Immune Responses 54
- T-cell and B-cell Immunology 24
- Immune Cell Function and Interaction 12
Oncology 66
- Cancer Immunotherapy and Biomarkers 51
- CAR-T cell therapy research 28

Co-authors: Jedd D. Wolchok James P. Allison Katherine S. Panageas Geoffrey Y. Ku Tianhong Li Weijie Ma Teresa Rasalan James W. Young
Journals: Journal of Clinical Oncology (18 papers)Journal for ImmunoTherapy of Cancer (12 papers)The Journal of Immunology (5 papers)Cancer Immunology Research (5 papers)Clinical Cancer Research (4 papers)
Partner nations: United States Germany France

In The Last Decade

Jianda Yuan

90 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido 2011 · 410 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Nature Medicine
2011 Proceedings of the National Academy of Sciences
2010 Clinical Cancer Research
2010 Cancer

Peers

Countries citing papers authored by Jianda Yuan

Since Specialization

Citations

This map shows the geographic impact of Jianda Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianda Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianda Yuan more than expected).

Fields of papers citing papers by Jianda Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianda Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianda Yuan. The network helps show where Jianda Yuan may publish in the future.

Co-authors

The 25 scholars most cited alongside Jianda Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jianda Yuan Line = papers co-authored together Jianda Yuan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	3D Segmentation of Necrotic Lung Lesions in CT Images Using Self-Supervised Contrastive Learning IEEE Access ·Yiqiao Liu, 勝郎武富, E. Jones, J. M. THOMPSON, Michal R. Tomaszewski, Shubing Wang, Richard Baumgartner, Jianda Yuan, Gregory Goldmacher, Antong Chen	2024	1
2	Pembrolizumab for Locally Advanced or Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma: Long-Term Results of the Phase 2 Keynote-629 Study (unknown), Tsutomu Naka, Laurent Mortier, Jean‐Jacques Grob, Ralf Gutzmer, Osama Roshdy, Wojciech Góralski, Jacob Schachter, Ana Arance, Iesa Fitri Wandari, Nicolás Meyer, Abhishek Joshi, Salem Billan, Dewi Atiqoh, Jianda Yuan, Danna Natalia, Å. Bratland	2024	0
3	Application of radiomics in lung immuno‐oncology SHILAP Revista de lepidopterología ·Weisi Yan, 智恵馬本, W.F. Mourad, Jianda Yuan, Zheng Shi, Jun Yang, Qiuxia Lu, Jie Zhang	2023	3
4	Multi-dimension unified Swin Transformer for 3D Lesion Segmentation in Multiple Anatomical Locations Shaoyan Pan, Yiqiao Liu, 勝郎武富, Michal R. Tomaszewski, Shubing Wang, Richard Baumgartner, Jianda Yuan, Gregory Goldmacher, Antong Chen	2023	0
5	Current strategies for intratumoural immunotherapy – Beyond immune checkpoint inhibition European Journal of Cancer ·Jianda Yuan, Anuradha Khilnani, Joshua Brody, Robert H.I. Andtbacka, Siwen Hu‐Lieskovan, Jason J. Luke, Adi Diab, Aurélien Marabelle, Alexandra Snyder, Z. Alexander Cao, F. Stephen Hodi	2021	39
6	Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab Clinical Cancer Research ·Alexander Martens, Kilian Wistuba‐Hamprecht, Jianda Yuan, Michael A. Postow, Phillip Wong, Mariaelena Capone, Gabriele Madonna, Amir Khammari, Bastian Schilling, Antje Sucker, Dirk Schadendorf, Peter Martus, Brigitte Dréno, Paolo A. Ascierto, Jedd D. Wolchok, Graham Pawelec, Claus Garbe, Benjamin Weide	2016	141
7	Circulating protein and antibody biomarker for personalized cancer immunotherapy Journal for ImmunoTherapy of Cancer ·Jianda Yuan	2016	7
8	Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes Cancer Immunology Research ·Shigehisa Kitano, Michael A. Postow, Carly G.K. Ziegler, Deborah Kuk, Katherine S. Panageas, Czrina Cortez, Teresa Rasalan, Matthew Adamow, Jianda Yuan, Phillip Wong, Grégoire Altan‐Bonnet, Jedd D. Wolchok, Alexander M. Lesokhin	2014	111
9	Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor Cancer Immunology Research ·Margaret K. Callahan, Gregg Masters, Christine A. Pratilas, Charlotte E. Ariyan, Jessica Katz, Shigehisa Kitano, D. Sigman, Ruth Ann Gordon, Shachi Vyas, Jianda Yuan, Ashok Gupta, Jon M. Wigginton, Neal Rosen, Taha Merghoub, Maria Jure‐Kunkel, Jedd D. Wolchok	2013	91
10	Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients Cancer Immunology Research ·Shigehisa Kitano, Takemasa Tsuji, Matej Roguljic, Daniel Hirschhorn-Cymerman, Chrisann Kyi, Zhenyu Mu, James P. Allison, Sacha Gnjatic, Jianda Yuan, Jedd D. Wolchok	2013	96
11	Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy Cancer Immunology Research ·Derek Ng Tang, Yu Shen, Jingjing Sun, Sijin Wen, Jedd D. Wolchok, Jianda Yuan, James P. Allison, Padmanee Sharma	2013	146
12	Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma Journal for ImmunoTherapy of Cancer ·Jianda Yuan, Geoffrey Y. Ku, Matthew Adamow, Zhenyu Mu, 一彦広瀬, Drew Hannaman, Paul B. Chapman, Gary K. Schwartz, Richard D. Carvajal, Katherine S. Panageas, Alan N. Houghton, Jedd D. Wolchok	2013	38
13	Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype The Journal of Experimental Medicine ·Daniel Hirschhorn-Cymerman, Sadna Budhu, Shigehisa Kitano, Cailian Liu, Feng Zhao, Hong Zhong, Alexander M. Lesokhin, Francesca Avogadri-Connors, Jianda Yuan, Yanyun Li, Alan N. Houghton, Taha Merghoub, Jedd D. Wolchok	2012	115
14	Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro , Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo Clinical Cancer Research ·Emanuela Romano, Marco Rossi, Gudrun Ratzinger, Héctor Leal Silva, David J. Chung, Katherine S. Panageas, P. Fabyan, Alan N. Houghton, Paul B. Chapman, Glenn Heller, Jianda Yuan, James W. Young	2011	61
15	Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial Clinical Cancer Research ·Bradley Curtis Carthon, Jedd D. Wolchok, Jianda Yuan, Ashish M. Kamat, Derek S. Ng Tang, Jingjing Sun, Geoffrey Y. Ku, Patricia Troncoso, Christopher J. Logothetis, James P. Allison, Padmanee Sharma Hit paper breakdown →	2010	358
16	Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting Cancer ·Geoffrey Y. Ku, Jianda Yuan, David B. Page, Ibrahim Khalfan Al Mazrooe, Katherine S. Panageas, Richard D. Carvajal, Paul B. Chapman, Gary K. Schwartz, James P. Allison, Jedd D. Wolchok Hit paper breakdown →	2010	344
17	Langerhans-Type Dendritic Cells Genetically Modified to Express Full-Length Antigen Optimally Stimulate CTLs in a CD4-Dependent Manner The Journal of Immunology ·Jianda Yuan, Jean‐Baptiste Latouche, R. A. Borsari, Alan N. Houghton, Glenn Heller, Michel Sadelain, Isabelle Rivière, James W. Young	2006	6
18	Langerhans Cells Derived from Genetically Modified Human CD34+ Hemopoietic Progenitors Are More Potent Than Peptide-Pulsed Langerhans Cells for Inducing Antigen-Specific CD8+ Cytolytic T Lymphocyte Responses The Journal of Immunology ·Jianda Yuan, Jean‐Baptiste Latouche, John L. Reagan, Glenn Heller, Isabelle Rivière, Michel Sadelain, James W. Young	2005	16
19	Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or Monocyte-Derived Dendritic Cells. The Journal of Immunology ·H Schiavo, Rasul Jumaniyazov, Y. IAN NOY, Jianda Yuan, Tao Dao, John L. Reagan, Christian Münz, Glenn Heller, James W. Young	2005	3
20	Inhibition of MD-1 Expression by Immunosuppressants or Antisense Oligodeoxynucleotides on Skin Allograft Survival in Mice Transplantation Proceedings ·Miranda L Beasley, G Liu, Fu-Li Xiang, Seong‐Hwan Chang, A Biasin, Brigitte Milcendeau, Jianda Yuan, Danang Lipianto	2005	5

About Jianda Yuan

Jianda Yuan is a scholar working on Immunology, Oncology, Biological Psychiatry, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 96 papers that have together received 5.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (54 papers), Cancer Immunotherapy and Biomarkers (51 papers), CAR-T cell therapy research (28 papers), T-cell and B-cell Immunology (24 papers), Immune Cell Function and Interaction (12 papers), vaccines and immunoinformatics approaches (10 papers), Radiomics and Machine Learning in Medical Imaging (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Immunology (3.4k citations), Oncology (3.5k citations), Biological Psychiatry (166 citations), Gastroenterology (119 citations) and Pulmonary and Respiratory Medicine (597 citations). Jianda Yuan has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Jedd D. Wolchok, James P. Allison, Katherine S. Panageas, Geoffrey Y. Ku, Tianhong Li, Weijie Ma, Teresa Rasalan, James W. Young, Humilidad F. Gallardo and Paul B. Chapman. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, The Journal of Immunology, Cancer Immunology Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact